Results with Optilume consistent in clinical trials and real world, regardless of prostate ...

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...

The Urocross® Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is ...

As men age, their bodies go through many natural changes. One such change, often less spoken about, is the enlargement of the ...

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia: Sunnyvale, California Thu ...

BECKLEY, WV (WVNS) — Dr. Lynetta Payne, a urologist at Raleigh General Hospital, has reached the milestone of 200 successful ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch well beyond its original purpose? That’s exactly the twist happening with a ...

Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...

In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score improvements.

Onlymyhealth is a resource-house of health information and medical updates on healthy life ideas. Get closer to healthy living with the help of expert advice on weight loss, cancer health, pregnancy, ...

Zuellig Pharma acquires Cialis from Lilly in three additional markets in Asia: Singapore Saturday, March 14, 2026, 11:00 Hrs [IST] Zuellig Pharma, a leading healthcare solutions c ...